Aspen API

Pleased to join #cdmolive ! Dr. Rajiv Grover and Shree Wood will be joining in behalve of Aspen API. For companies sourcing generic commercial APIs and / or advancing with new molecule APIs through Phase IIb and Phase III, Aspen API offers the ideal balance of development expertise, manufacturing excellence, and commercial readiness. We are specialized in HP-APIs, Peptides and Steroids, either by tech transfers or own development. Look forward to meeting you!

Thank you PharmaSource for giving us the possibility to highlight the importance of this topic. At Aspen API we are committed to continuously improve our operations through smart, target initiatives that support both sustainability and support reliability for our customers. #sustainability #CMO #ContinuousImprovement

Featured in Life Sciences Review Europe In the CDMO market, success is about more than manufacturing capacity. It’s about having a partner who listens, responds, and is fully committed to your project. As a mid-sized CDMO, Aspen API combines technical expertise with what our customers value most: full customer attention. We are proud to be featured in Life Sciences Review Europe, in which Marcella van Dinther shares the Aspen API vision on why personalized partnerships remains a key differentiator in today’s CDMO landscape. Digital Edition (Page 42): https://lnkd.in/eqaGgFmB Online Feature: https://lnkd.in/ehXEuRAG #CDMO #PeptideManufacturing #PharmaPartner #CustomerCentricity #DrugDevelopment #PharmaceuticalManufacturing #AspenAPI #LifeSciences #Partnerships #MoreThanJustAnAPI

Last month, Narcis Brugada and Arjan Monteny attended #CDMOLive, organized by PharmaSource in Rotterdam, where Arjan had the opportunity to speak with Maurice van Rotterdam from Sciential - Digital Marketing for Life Sciences Brands about our Aspen API capabilities and the current opportunities within the CDMO Industry. It was a pleasure for them connecting with so many fellow industry professionals at an event that not only showcased where the industry is heading, but also reinforced the importance of strong partnerships and collaboration. Their key takeaway message that stood out to them during the conference was: the importance of cooperation and transparent communication.  Thank you to everyone who contributed to the discussions. We look forward to continuing these conversations and hopefully seeing many of you again next year in Rotterdam. #CDMOLive #API #CDMO

𝗚𝗠𝗣 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝘁 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 𝗨𝗦𝗗 𝟭𝟭.𝟭𝟯 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟲 | 𝗡𝗼𝘃𝗮𝘁𝗿𝗲𝗻𝗱𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 The global GMP Peptide Manufacturing Services market is witnessing exceptional growth driven by the rapid expansion of peptide-based therapeutics, increasing investments in GLP-1 drugs, rising demand for outsourced pharmaceutical manufacturing, and growing peptide pipelines targeting oncology, metabolic disorders, rare diseases, and infectious diseases. According to recent market intelligence analysis, the market was valued at approximately USD 3.29 Billion in 2025 and is projected to reach nearly USD 11.13 Billion by 2036, expanding at a CAGR of 18.9% during the forecast period. 𝗪𝗵𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗻𝗴 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲: • Identify high-growth opportunities within peptide therapeutics and CDMO markets • Benchmark competitors and manufacturing capabilities • Analyze evolving regulatory and GMP compliance requirements • Evaluate capacity expansion and outsourcing trends • Understand emerging demand from obesity, diabetes, oncology, and rare disease therapies 𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀: • Rapid expansion of GLP-1 and obesity drug development pipelines • Increasing outsourcing of peptide API manufacturing activities • Growing demand for complex and long-chain peptide synthesis capabilities • Rising investments in GMP-compliant peptide production facilities • Increasing adoption of advanced purification and analytical technologies • Expansion of peptide therapeutics across oncology, metabolic, and rare disease applications 𝗠𝗮𝗿𝗸𝗲𝘁 𝗕𝘆 𝗧𝘆𝗽𝗲: • Process Development • Clinical GMP Manufacturing • Commercial GMP Manufacturing • Other 𝗠𝗮𝗿𝗸𝗲𝘁 𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: • Pharmaceutical Companies • Biotechnology Companies • Academic and Research Institutions • Others 𝗠𝗮𝗿𝗸𝗲𝘁 𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: • North America • Europe • Asia-Pacific • South America • Middle East & Africa 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: PolyPeptide Group Bachem Piramal Pharma Solutions Almac Group Aspen API Neuland Laboratories Limited USV PRIVATE LIMITED Aurigene Pharmaceutical Services Limited 𝗔𝘁 Novatrends Market Intelligence, 𝘄𝗲 𝗵𝗲𝗹𝗽 𝗴𝗹𝗼𝗯𝗮𝗹 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝘆𝗲𝗮𝗿𝗹𝘆 "𝗿𝗲𝘃𝗲𝗻𝘂𝗲 𝗴𝗿𝗼𝘄𝘁𝗵" 𝗯𝘆 𝗮𝘀𝘀𝗶𝘀𝘁𝗶𝗻𝗴 𝘁𝗵𝗲𝗺 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝘁𝗵𝗲 𝗰𝘂𝗿𝗿𝗲𝗻𝘁 & 𝗳𝘂𝘁𝘂𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁: https://lnkd.in/d-JmvTWB #GMPPeptideManufacturing #PeptideAPI #PharmaceuticalManufacturing #CDMO #Biotechnology #GLP1 #DrugDevelopment #PeptideTherapeutics #ContractManufacturing #Biopharmaceuticals #PharmaIndustry #ClinicalTrials #LifeSciences #MarketResearch #BusinessGrowth #HealthcareInnovation

“Driven by Purpose”! Daily and here at BIO International, San Diego, CA! Let's explore how we can serve the same purpose! You can reach out to me via BioPartnerimg! June 22-25, 2026 #aspenapi #cdmo #cmo #smallmolecules #peptides #HPAPI #BIOInternational2026 #BIO2026

📍 BIO International Convention – San Diego (June 22–25) The global biotech community is here — and so are we. With over 20,000 industry leaders coming together, BIO is where partnerships are built, pipelines accelerate, and innovation turns into real-world impact. Why meet Aspen API at BIO International Convention? ✅ to turn complexity into certainty From early development to commercial manufacturing, we support your API journey end‑to‑end with proven CDMO expertise and regulatory reliability. ✅ De-risk your supply chain With decades of experience and a strong track record in complex APIs, peptides, and HPAPIs, we help you secure continuity and quality when it matters most. ✅ Build real partnerships—not just transactions BIO is all about connection, and we believe in long-term collaboration to bring therapies to patients faster. 💬 Whether you are exploring new molecules, scaling up, or looking to optimize your current supply strategy—this is the moment to connect. 👉 Meet our colleague Shree Wood, CDMO Senior Business Development Manager, present in San Diego and discover how Aspen API can support your next breakthrough. Contact: swood@us.aspenpharma.com #BIO2026 #CDMO #API #PharmaPartners #Biotech #AspenAPI #Pharmaceuticals #Collaboration

Today is Father’s Day, and we are shining the spotlight on fathers who never miss a responsibility, a milestone, or a moment that matters — today, we celebrate YOU. Fatherhood is perhaps one of life’s greatest responsibilities — teaching, guiding, protecting, and instilling values that shape character for years to come. Few roles carry greater purpose or influence. Father’s Day is an opportunity to honour the men who help shape lives through guidance, sacrifice, resilience, and unwavering support. It is a celebration of fathers, grandfathers, father figures, mentors, and role models who continue to leave lasting impressions through everyday acts of care and leadership. To every father and every man who has stepped forward to support, guide, encourage, and help shape the lives of children with integrity, kindness, and strength — thank you. Your sacrifices matter. Your lessons endure. Your presence leaves a legacy. As Billy Graham once said: “A good father is one of the most unsung, unpraised, unnoticed, and yet one of the most valuable assets in our society.” Happy Father’s Day to all fathers and father figures! Thank you for lighting the way forward and for the impact you continue to make every day. #AspenWeCare #FathersDay2026 #CelebratingFatherhood #ThankYouDad #EverydayHeroes #ProudlyAspen #FatherFigures #LeadershipAndLegacy #FamilyValues #HonouringFathers #TogetherWeGrow #AspenAPI Aspen API Vandaag is het Vaderdag — een moment om stil te staan bij vaders die er altijd zijn en geen moment, mijlpaal of verantwoordelijkheid voorbij laten gaan. Vandaag zetten we júllie in het zonnetje. Vader zijn is misschien wel één van de belangrijkste rollen in het leven: begeleiden, beschermen, richting geven en waarden meegeven die een leven lang doorwerken. Weinig rollen hebben zoveel betekenis en impact. Vaderdag is hét moment om waardering te tonen voor de mannen die levens helpen vormen — door hun inzet, opofferingen, veerkracht en onvoorwaardelijke steun. We vieren niet alleen vaders, maar ook grootvaders, vaderfiguren, mentoren en rolmodellen die elke dag het verschil maken met hun zorg en leiderschap. Aan elke vader en aan elke man die zich inzet om kinderen te ondersteunen, te begeleiden en te inspireren met integriteit, warmte en kracht — dank je wel. Jouw inspanningen maken het verschil. Jouw lessen blijven bij. Jouw aanwezigheid laat een blijvende impact achter. Zoals Billy Graham het mooi zei: “Een goede vader is één van de meest onopgemerkte en ondergewaardeerde, maar tegelijkertijd één van de meest waardevolle pijlers van onze samenleving.” Fijne Vaderdag aan alle vaders en vaderfiguren! Dank voor jullie voorbeeld, jullie inzet en de impact die jullie elke dag maken. #AspenWeCare #FathersDay2026 #CelebratingFatherhood #ThankYouDad #EverydayHeroes #ProudlyAspen #FatherFigures #LeadershipAndLegacy #FamilyValues #HonouringFathers #TogetherWeGrow

Another milestone for life sciences in Oss. The construction agreement for the new Panther building at Pivot Park has officially been signed. With construction of the fit-out of the building starting on 15 June 2026, Aspen Oss and Pivot Park are taking the next step towards a future-ready laboratory and office facility designed to support innovation, collaboration and sustainable growth. “This project with Aspen Oss marks another important step in the growth of our science park. The Panther building will further strengthen the position of Pivot Park and Oss as a leading hub for life sciences and biopharmaceutical innovation” says Brigitte Drees (CEO Pivot Park). Read more about the project here: https://lnkd.in/e8T7NpBC